XML 260 R97.htm IDEA: XBRL DOCUMENT v3.22.1
Related party transactions (Narrative) (Details)
1 Months Ended 12 Months Ended
Mar. 08, 2022
shares
Jun. 30, 2021
shares
Feb. 28, 2021
USD ($)
shares
Dec. 31, 2021
CAD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
shares
Dec. 31, 2019
USD ($)
Dec. 31, 2019
USD ($)
Disclosure of transactions between related parties [line items]                
Mixed decision - share grant permitted | shares 536,979              
Share-based payments expense         $ 6,881,641 $ 7,045,994 $ 9,385,984  
Director                
Disclosure of transactions between related parties [line items]                
Directors remuneration expense         757,690 246,226   $ 153,109
Share-based payments expense         466,546 238,703   0
Board Chair and Chief Executive Officer, and certain other directors                
Disclosure of transactions between related parties [line items]                
Number of shares issued for compensation bonus | shares     1,349,764          
Number of shares cancelled for compensation bonus | shares   156,278            
Share-based payments expense     $ 3,576,875          
Raza Bokhari                
Disclosure of transactions between related parties [line items]                
Number of shares issued for compensation bonus | shares     1,173,709          
Share-based payments expense     $ 3,110,330          
Certain other directors                
Disclosure of transactions between related parties [line items]                
Number of shares issued for compensation bonus | shares     176,055          
Share-based payments expense     $ 466,545          
Chief Executive Officer                
Disclosure of transactions between related parties [line items]                
Payment of expenses         $ 262,834 1,445,043   $ 567,468
Related party payables           $ 355,778    
Independent directors                
Disclosure of transactions between related parties [line items]                
Directors remuneration expense       $ 60,000        
Additional remuneration as chairman of audit committee       20,000        
Additional remuneration as chairman of compensation committee       10,000        
Key management and directors                
Disclosure of transactions between related parties [line items]                
Number of shares issued for compensation bonus | shares           1,676,066    
Share-based payments expense           $ 4,602,301    
Reimbursed expenses incurred in relation to requisitioning, calling and holding the shareholders' meeting       $ 1,334,158        
FSD Biosciences | President of FSD                
Disclosure of transactions between related parties [line items]                
Related party payables           $ 21,876